SEC Comment Letter 0000000000-23-010208 to SYNLOGIC, INC. (SYBX)
SYNLOGIC, INC.
Date: Sept. 15, 2023 · CIK: 0001527599 · Accession: 0000000000-23-010208
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-274421
Letter
United States securities and exchange commission logo September 14, 2023 Aoife Brennan President, Chief Executive Officer and Director SYNLOGIC, INC. 301 Binney Street, Suite 402 Cambridge, MA 02142 Re:SYNLOGIC, INC. Registration Statement on Form S-1 Filed September 8, 2023 File No. 333-274421 Dear Aoife Brennan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Cindy Polynice at 202-551-8707 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Nishant M. Dharia, Esq.
Show Raw Text
United States securities and exchange commission logo
September 14, 2023
Aoife Brennan
President, Chief Executive Officer and Director
SYNLOGIC, INC.
301 Binney Street, Suite 402
Cambridge, MA 02142
Re:SYNLOGIC, INC.
Registration Statement on Form S-1
Filed September 8, 2023
File No. 333-274421
Dear Aoife Brennan:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Cindy Polynice at 202-551-8707 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Nishant M. Dharia, Esq.